吉澤 一巳

Medicine & Life Sciences

1. (trans)-Isomer 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide 100%
2. Opioid Receptors 67%
3. sigma-1 receptor 45%
4. Ketamine 42%
5. TRK 820 40%
6. KNT 127 35%
7. Veratrine 26%
8. 2-hydrazino-1-methylpyridine 26%
9. N,N-dipropyl-2-(4-methoxy-3-(2-phenylethoxy)phenyl)ethylamine monohydrochloride 26%
10. Pentazocine 26%
11. Neurosteroids 26%
12. Dopamine D2 Receptors 25%
13. Anti-Anxiety Agents 25%
14. N-Methyl-D-Aspartate Receptors 24%
15. SA 4503 24%
16. Morphine 24%
17. Anxiety 23%
18. Methamphetamine 22%
19. N-Methyl-3,4-methylenedioxyamphetamine 21%
20. Receptor for Advanced Glycation End Products 20%
21. Olanzapine 19%
22. Cisplatin 19%
23. Pregnanolone 19%
24. Cues 19%
25. Trimebutine 18%
26. neuromedin U 18%
27. Phencyclidine 18%
28. Psychological Generalization 18%
29. 7-hydroxy-2-N,N-dipropylaminotetralin 17%
30. Neuralgia 17%
31. alphaxalone 17%
32. Cocaine 16%
33. Sodium Channel Blockers 15%
34. Dopamine D3 Receptors 15%
35. Hallucinogens 15%
36. Pharmaceutical Preparations 15%
37. Cell-Penetrating Peptides 14%
38. Brain 14%
39. Opioid Analgesics 14%
40. Amino Acid Transport System X-AG 14%
41. Hyperalgesia 13%
42. kappa Opioid Receptor 13%
43. Serotonin Receptors 13%
44. Intranasal Administration 13%
45. delta Opioid Receptor 13%
46. Methylphenidate 13%
47. Eicosapentaenoic Acid 13%
48. Olive Oil 12%
49. Muscular Atrophy 12%
50. hydroxide ion 12%